Skip to content
Save up to 80% on your medications — Fast delivery
Micogel
Guaranteed quality
Discreet shipping
Returns

Micogel

5 customer reviews
Delivery: 4–7 days
Secure payment methods
24/7 Support
Active ingredient: Miconazole
Package Per unit Price
SSL Secure
Certified pharmacy
Money-back guarantee

Micogel is a topical antifungal cream containing miconazole. It is for adults and older children with common fungal skin infections. It works by disrupting fungal cell membrane formation to help clear the infection as skin heals.

What is it?

Micogel is an antifungal medicine for fungal skin infections. It is used when symptoms like itching, redness, flaking, cracking, or a “spreading edge” rash suggest a dermatophyte infection (tinea) or another superficial fungal problem.

Composition

Active ingredient: miconazole nitrate (antifungal). Excipients may include gel-forming agents, purified water, humectants, and preservatives to stabilize the gel and support skin application; exact excipient list depends on the specific product version.

How to use?

Start with clean, dry skin. Apply Micogel in a thin film and keep to a steady routine.

A practical application routine:

  1. Wash the affected skin with mild soap or cleanser.
  2. Dry fully, including between toes and within folds.
  3. Apply a thin layer to the rash and a small margin of surrounding skin.
  4. Wash hands after application (unless hands are the treated area).
  5. Keep the area as dry as possible between applications.

Micogel Cream should be used in the dose and duration as prescribed by your doctor. Micogel Cream should be used regularly to get the most benefit from it.

Three short reminders matter. Do not rush. Do not stop early. Keep the area dry.

If you miss an application, apply it when you remember and return to your normal schedule. Doubling the amount rarely helps and often irritates.

For athlete’s foot, put Micogel on first, let it absorb for a few minutes, then apply moisturiser (if needed) to cracked skin. Putting moisturiser first can dilute the antifungal at the skin surface.

How does it work?

  • Route: topical (apply to skin only)
  • Dose: apply a thin layer to cover the affected area and 1–2 cm of surrounding skin (typical amount about 0.5–1 g per application; equals roughly a 1–2 cm ribbon of gel)
  • Frequency: 2 times/day (morning and evening)
  • Timing: apply on clean, dry skin; can be used regardless of meals
  • Duration: usually 2–4 weeks; continue for 7 days after symptoms resolve
  • Avoid: contact with eyes, mouth, and mucous membranes; do not apply to large broken skin areas

Indications

Micogel is a topical antifungal cream used to treat common fungal skin infections such as athlete’s foot, ringworm, and jock itch.

Micogel is commonly used for:

  • Athlete’s foot (tinea pedis): itching and peeling between toes, burning soles
  • Jock itch (tinea cruris): itchy rash in the groin folds, often with a defined border
  • Ringworm (tinea corporis): circular patches with a clearer center and a more active outer rim
  • Candidal skin infections: in warm, moist areas where skin rubs (under-breast, skin folds)

Two quick expectations help people use Micogel well. The skin can look calmer before the fungus is fully suppressed. Relapse happens when treatment stops too early.

If the rash is on the feet, treat both the visible rash and 1–2 cm around it, and keep socks/shoes dry; damp footwear is one of the most common reasons tinea pedis returns.

Comparison

Micogel is one option within topical antifungals. Alternatives can differ by active ingredient, spectrum, and how inflamed the skin is.

Choice is usually based on site of infection (feet vs groin vs folds), severity, suspected organism, and whether bacterial infection is also present. EMA guidance on topical antifungal use in skin infections supports matching the agent and formulation to the clinical picture rather than switching randomly after a few applications [4].

Contraindications

  • Hypersensitivity/allergic reaction to miconazole, miconazole nitrate, or other azole antifungals
  • Application to the eyes or inside the mouth
  • Use on a deep open wound, extensive raw skin, or a severe burn where a topical antifungal cream is unsuitable
  • Clinically significant interaction risk with warfarin and related anticoagulants (reported raised INR/bleeding risk) [3]

Not recommended for

Do not use Micogel if you have ever had an allergic reaction to miconazole or other azole antifungals. Do not apply it in or near the eyes or inside the mouth. Avoid using it on deep open wounds, large areas of raw/broken skin, or severe burns.

If you take blood thinners such as warfarin, tell a clinician before using Micogel because interactions have been reported and monitoring or an alternative may be needed [3].

Side effects

Most side effects from Micogel are local skin reactions where it is applied. They often settle as the skin adapts.

Commonly reported effects include:

  • Mild burning or stinging after application
  • Itching, redness, or irritation
  • Dryness or peeling

Less common, seek medical review sooner:

  • Worsening swelling, blistering, weeping, or severe pain
  • Signs of allergy like widespread hives or facial swelling
  • A rash that spreads rapidly beyond the treated area

Micogel F Ointment can cause dryness, and combined steroid–antifungal products can also thin skin when used too long on delicate areas. That risk is one reason clinicians keep steroid combinations time-limited and targeted.

One human detail that surprises people: the first few applications can sting more on fissured skin (heels, between toes). A thin layer and good drying technique usually makes that manageable.

Common mistakes

The same avoidable missteps show up again and again, and they explain most “Micogel didn’t work” stories.

  • Stopping when itch stops: symptoms can improve before fungal clearance.
  • Applying on wet skin: moisture dilutes the product and supports fungal growth.
  • Using a thick layer: more product can mean more irritation, not faster cure.
  • Treating only the center of the rash: ringworm grows outward; the edge is where active fungus sits.
  • Sharing towels or socks at home: it spreads spores and restarts infection cycles.
  • Mixing with potent steroid creams without a plan: this can alter the appearance of tinea (“tinea incognito”) and delay proper control.
If you treat the groin, put Micogel on after the skin is fully dry, then use loose, breathable clothing; tight synthetic fabric is a frequent trigger for recurrence.

Doctor opinions

In clinic, clinicians often judge response by two tracks: symptom relief and edge control. The itch may settle within days, yet the “active border” of ringworm can keep spreading if dosing is inconsistent.

Doctors also see a common pattern after gym or pool exposure: people treat only the visible rash but keep re-inoculating their feet from damp shoes, shared floors, or sweaty socks. That is why a dermatologist may ask about footwear habits, not just the cream used.

A second clinical reality is misdiagnosis. Eczema, psoriasis, and contact dermatitis can mimic fungal rashes, and steroid creams can temporarily improve redness while the fungus continues to grow underneath. When a rash worsens, changes shape, or keeps returning in the same place, clinicians often switch from self-treatment to confirmation by skin scraping and microscopy or culture.

One more detail from practice: if a patient reports a new rash that looks more angry after starting treatment, the first question is where the product was applied—eyes, mouth area, or broken skin can react strongly and needs different management.

Frequently asked questions

Most people feel less itch and irritation within a few days, yet visible scaling and edge activity can take longer to settle because the outer skin layers replace gradually. For athlete’s foot and ringworm, consistent daily use is usually needed for weeks, not days. If symptoms worsen or the rash keeps expanding, clinicians reassess the diagnosis and may confirm fungus by testing. WHO essential medicines guidance updated in 2026 lists topical azoles like miconazole as standard options for superficial fungal infections, with treatment duration driven by site and severity.

Facial skin is more reactive, and many facial rashes are not fungal. Clinicians often prefer diagnosis confirmation before putting antifungals near the eyes, because accidental eye exposure can cause marked irritation. If Micogel is used on the face, a very thin layer and careful handwashing after application reduces the chance of product transfer to the eyes. MOHAP patient safety materials in 2026 continue to emphasise avoiding eye contact with topical medicines and seeking review for persistent facial rashes [5].

A mild, brief sting can happen, especially on cracked skin or in folds where sweat and friction are present. Persistent burning, swelling, blistering, or pain suggests irritation or allergy and needs a change in plan. Many patients reduce stinging by applying after full drying and by using a thinner film rather than a thick layer. EMA safety reviews for topical antifungals describe local irritation as a common, usually mild effect that resolves with appropriate use.

Yes, and it can help if fungal infection has led to dryness and cracking, especially on feet. Put Micogel on first so the antifungal contacts the skin surface, then moisturise after it absorbs. Using moisturiser first can act like a barrier and lower contact between miconazole and the affected stratum corneum. WHO guidance in 2026 supports adjunct skin care (drying, barrier support) alongside antifungals for tinea pedis to reduce recurrence risk.

Relapse usually means the fungus was suppressed but not fully cleared, or reinfection occurred from socks, shoes, towels, or close contacts. A common pattern is stopping when itch stops, even though the fungal load at the border remains active. Another reason is a wrong diagnosis, such as eczema, where antifungal use gives partial relief but does not address the underlying inflammation driver. MOHAP clinical awareness messaging in 2026 highlights recurrence as a prompt to review diagnosis and hygiene sources, not just to reapply more product.

Topical miconazole has low systemic absorption when used on intact skin, which is why clinicians often consider it acceptable when there is a clear need. Pregnancy and breastfeeding still change the risk-benefit balance, and the treated area matters, since broken skin and large areas can increase absorption. Avoid applying on the breast or nipple area to prevent infant exposure during feeds. EMA monographs and safety summaries for topical azoles describe pregnancy use as clinician-guided, with attention to exposure area and duration.

Front view Front view
Side view Side view
Back view Back view

Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (9.4x4.3x0.3 in. or 24x11x0.7 cm) and its contents cannot be seen.

Micogel — Comparison with alternatives

Micogel Cream vs. Ointment: Understanding the Different Formulations

Micogel on this page is a cream in a tube, which usually feels lighter on the skin and tends to be preferred for hairy areas, skin folds, or places where you want faster absorption and less greasiness.

An ointment (in general) is oilier and more occlusive than a cream. It can be useful when skin is very dry and cracked, but the occlusion can also trap moisture in some areas, which fungi like. The formulation choice is clinical, not cosmetic.

Important Safety Advice When Using Micogel

Micogel Cream is for external skin use. Avoid contact with eyes, mouth, and open wounds.

Pregnant women should consult their doctor before using Micogel Cream. Breastfeeding women should consult their doctor before using Micogel Cream.

Extra safety points that matter in real life:

  • Avoid covering large areas with airtight dressings unless your clinician specifically advised it, since occlusion can increase irritation.
  • Be careful around the genital area; skin there absorbs more and irritates faster.
  • If the rash is on the face or near eyes, clinicians often prefer a confirmed diagnosis first because many facial rashes mimic fungus.

A practical limitation: if there is no improvement after a reasonable treatment window, clinicians reassess the diagnosis, adherence, and reinfection sources. Persistent rashes sometimes need oral antifungals or a different diagnosis pathway guided by local clinical standards and essential medicines guidance [2].

Reviews and Experiences

H
Hassan, 34
Dubai
3 weeks
Verified
The itching between my toes eased after about four days. By the second week the peeling looked much better. I had to change socks midday at work or it came back.
14/02/2026
M
Mariam, 28
Sharjah
2 weeks
Verified
It worked, but the first two applications stung more than I expected. Using a smaller amount and making sure the skin was completely dry made it tolerable.
03/11/2025
R
Rashid, 41
Abu Dhabi
4 weeks
Verified
The center looked fine after a week, so I stopped. It returned and spread wider. Second time I kept going for the full month and it cleared.
20/01/2026
E
Elena, 32
Al Ain
10 days
Verified
Redness reduced quickly, but sweating restarted it. I started drying the area after showers and wore looser cotton tops; that made a bigger difference than applying more cream.
08/09/2025
O
Omar, 57
Dubai
2 weeks
Verified
I used it as directed, but I kept wearing the same damp trainers. The cream helped a little, but the rash kept coming back until I changed my shoes and socks routine.
05/03/2026

Sources

  1. European Medicines Agency (EMA) (2026). Miconazole: overview of pharmacology, indications, and adverse effects for topical use.
  2. World Health Organization (WHO) (2026). WHO Model List of Essential Medicines: medicines for fungal diseases (topical azoles).
  3. PubMed (2025). Case reports and reviews on miconazole–warfarin interaction and INR elevation.
  4. European Medicines Agency (EMA) (2025). Guidance on management of superficial fungal infections and appropriate topical antifungal selection.
  5. MOHAP (Ministry of Health and Prevention) (2026). Patient medication safety guidance for topical skin medicines (safe application and red flags).